Skip to main content
NATCON24 Main banner
Back

Clinical Practices

MTS6 - An Update on Long-acting Medications (LAMs): A Steadily Increasing Range of Options

Tuesday, April 16, 2024
3:15 PM – 4:15 PM CT
Location: 124, Level 1, ACCC
NASW CCB NADAAC NBCC ACCME APA ANCC NY-MHC NY-SW
There is an increasing range of options available for Long-Acting Medications (LAMs), both for the treatment of schizophrenia and opioid use disorder. This session will review available treatment options, and highlight the utilization of LAMs as a strategy to address medication non-adherence.

Learning Objectives:

  • Understand how clinical practice guidelines have evolved to incorporate LAMs, including for the treatment of schizophrenia and opioid use disorder.
  • Identify appropriate utilization of LAMs as a first-line treatment rather than solely an adherence strategy.
  • Differentiate the wide range of products available, including newer options, such as those approved for the treatment of opioid use disorder.